Correlation Between NAYA Biosciences, and MaxCyte

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NAYA Biosciences, and MaxCyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NAYA Biosciences, and MaxCyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NAYA Biosciences, and MaxCyte, you can compare the effects of market volatilities on NAYA Biosciences, and MaxCyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NAYA Biosciences, with a short position of MaxCyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of NAYA Biosciences, and MaxCyte.

Diversification Opportunities for NAYA Biosciences, and MaxCyte

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between NAYA and MaxCyte is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding NAYA Biosciences, and MaxCyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MaxCyte and NAYA Biosciences, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NAYA Biosciences, are associated (or correlated) with MaxCyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MaxCyte has no effect on the direction of NAYA Biosciences, i.e., NAYA Biosciences, and MaxCyte go up and down completely randomly.

Pair Corralation between NAYA Biosciences, and MaxCyte

Given the investment horizon of 90 days NAYA Biosciences, is expected to generate 3.38 times more return on investment than MaxCyte. However, NAYA Biosciences, is 3.38 times more volatile than MaxCyte. It trades about 0.03 of its potential returns per unit of risk. MaxCyte is currently generating about -0.02 per unit of risk. If you would invest  149.00  in NAYA Biosciences, on September 2, 2024 and sell it today you would lose (51.00) from holding NAYA Biosciences, or give up 34.23% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

NAYA Biosciences,  vs.  MaxCyte

 Performance 
       Timeline  
NAYA Biosciences, 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in NAYA Biosciences, are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, NAYA Biosciences, sustained solid returns over the last few months and may actually be approaching a breakup point.
MaxCyte 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MaxCyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

NAYA Biosciences, and MaxCyte Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NAYA Biosciences, and MaxCyte

The main advantage of trading using opposite NAYA Biosciences, and MaxCyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NAYA Biosciences, position performs unexpectedly, MaxCyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MaxCyte will offset losses from the drop in MaxCyte's long position.
The idea behind NAYA Biosciences, and MaxCyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities